VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 52 filers reported holding VECTIVBIO HLDG AG in Q2 2023. The put-call ratio across all filers is 0.68 and the average weighting 1.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,592,602 | $20,028,000 | 5.85% |
| Novo Holdings A/S | 3,522,019 | $27,190,000 | 1.41% |
| Cormorant Asset Management, LP | 2,226,128 | $17,197,000 | 0.70% |
| NEA Management Company, LLC | 67,069 | $51,811,000 | 0.62% |
| Bpifrance SA | 2,806,217 | $21,678,000 | 0.50% |
| Orbimed Advisors | 5,123,304 | $39,578,000 | 0.44% |
| Eventide Asset Management | 2,339,044 | $17,599,000 | 0.23% |
| Tekla Capital Management LLC | 756,502 | $5,372,000 | 0.17% |
| Pinz Capital Management, LP | 48,073 | $371,000 | 0.17% |
| PFM Health Sciences, LP | 544,706 | $4,208,000 | 0.12% |